Vivos (RDGL) Capital Leases (2010 - 2011)
Vivos' (RDGL) quarterly Capital Leases came in at $711556.0 in Q3 2011, down 13.41% quarter-over-quarter from $821792.0 in Q2 2011.
Powered by 
Analysis
Vivos (RDGL) Capital Leases (2010 - 2011) Analysis & Trends
Vivos has disclosed Capital Leases across 2 years of filings, most recently posting $711556.0 for Q3 2011.
- In Q3 2011, Capital Leases changed N/A year-over-year to $711556.0; the TTM figure through Sep 2011 stood at $711556.0 (changed N/A YoY), while the FY2010 annual figure was $1.0 million, changed N/A from the prior year.
- Capital Leases came in at $711556.0 for Q3 2011 at Vivos, down from $821792.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.0 million in Q4 2010 to a low of $711556.0 in Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | 711,556.00 |
| Jun 30, 2011 | 821,792.00 |
| Dec 31, 2010 | 1.03 Mn |